Table 4.
Artemisinin pharmacokinetic parameters determined on days −5, 1 and 5 in Group AS (n = 10, artesunate was given on day −5 and from day 1 through day 5, artemisinin was given on days 1 and 5) and in Group AM (n = 10, artemisinin was given on day −5 and from day 1 through day 5, artesunate was given on days 1 and 5). Values of parameters are shown as geometric mean (95% CI).
| Artemisinin parameters | Day −5 | Day 1 | Day 5 |
|---|---|---|---|
| Group AS | |||
| AUC(0, t) (nmol l−1 h) | 8339 | 5219** | |
| (7153, 9720) | (4028, 6761) | ||
| AUC(0, ∞) (nmol l−1 h) | 9056 | 5638** | |
| (7652, 10719) | (4320, 7358) | ||
| CL/F (l h−1) | 196 | 315** | |
| (165, 232) | (241, 410) | ||
| t½ (h) | 2.48 | 2.50 | |
| (2.05, 3.01) | (1.99, 3.13) | ||
| Cmax (nmol l−1) | 2794 | 2047* | |
| (2353, 3317) | (1546, 2710) | ||
| Group AM | |||
| AUC(0, t) (nmol l−1 h) | 7733*** | 5081 | 1572*** |
| (5674, 10539) | (4320, 5975) | (1051, 2350) | |
| AUC(0, ∞) (nmol l−1 h) | 8555** | 5763 | 1807*** |
| (6212, 11781) | (4813, 6901) | (1249, 2614) | |
| CL/F (l h−1) | 207** | 308 | 981*** |
| (151, 285) | (257, 368) | (678, 1420) | |
| t½ (h) | 2.21 | 2.97 | 2.53 |
| (1.72, 2.84) | (2.27, 3.88) | (1.99, 3.23) | |
| Cmax (nmol l−1) | 2408** | 1803 | 629*** |
| (1824, 3179) | (1413, 2299) | (414, 956) | |
P < 0.05
P < 0.01
P < 0.001; (compared with the values on day 1).